Exome Asset Management’s Immatics IMTX Stock Holding History

Exome Asset Management’s Portfolio IMTX Stock Details IMTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-129,900	Closed	-$1.37M	–	62
2023 Q4	$1.37M	Buy	+129,900	New	+$1.2M	1.35%	29

Other funds holding IMTX

RTW Investments New York $10B AUM 135.35% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return

Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

PBA

Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return

Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return

Sofinnova Investments Menlo Park, California $2.63B AUM 117.41% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Exome Asset Management's IMTX Position: Q1 2024 in Review

Exome Asset Management sold out of Immatics (IMTX) in Q1 2024, closing a stake of 129,900 shares — an estimated $1.37M sold.

Exome Asset Management first reported a position in IMTX in Q4 2023 and held it in 1 quarter. The position peaked at $1.37M in Q4 2023. 78 funds tracked by Wall St. Rank hold IMTX as of Q1 2024.

Exome Asset Management reported no remaining Immatics position as of Q1 2024 after selling out during the quarter.
Exome Asset Management sold 129,900 Immatics shares in Q1 2024, an estimated $1.37M.
Exome Asset Management first reported a position in Immatics in Q4 2023 and held it in 1 quarter.
Exome Asset Management's Immatics position peaked at $1.37M in Q4 2023.
78 funds tracked by Wall St. Rank held Immatics as of Q1 2024.

Based on Exome Asset Management's 13F filing for Q1 2024, filed 15 May 2024.